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Much effort has been devoted to updating the practice of 
pathology in the current management of cancers, arising 
from increasing knowledge and availability of new 
technologies. In addition to a wide variety of new tools 
entailing molecular analysis and immunohistochemistry 
with ever-expanding lists of antibodies, there has also 
been a significant evolution in the conventional practice 
of histopathology. This has occurred, in parallel with the 
evolving changes in the practice of surgery, medicine, 
and other subspecialties. In this issue of the Hong 
Kong Medical Journal, two papers1,2 on the practice of 
pathology highlight such changes in routine practice in 
the management of cancers.
Examination of sentinel lymph nodes in 
breast cancer management
Leung et al1 reported their experience with intra-operative 
examination of sentinel lymph nodes (SLNs) in the course 
of breast cancer management in a series of 300 patients. 
Their frozen sections yielded a correct diagnosis in 85% 
of the patients and a false negative rate (FNR) of 15%; the 
latter figure being comparable to rates ranging between 
7 and 12% reported in multicentre studies.3,4
 Identification and assessment of SLNs in breast 
cancer has greatly altered the surgical management of 
this disease. Sentinel lymph node biopsy, with intensive 
histological work-up using multiple level sectioning3 
and immunohistochemistry,5 has gained popularity to 
replace the routine level I and II axillary lymph node 
dissection for women with clinically node–negative T1 
and T2 breast cancer. Concurrently, different groups, for 
example the American Society of Clinical Oncology have 
published guidelines in the use of SLNs for this purpose, 
though notably their use is not recommended in some 
special circumstances.4
 Patients with negative SLN represent a subgroup 
of breast cancer patients with better prognosis with their 
pN0 status. Therefore, to be effective in guiding proper 
adjuvant therapy after removal of the primary cancer, 
the results of SLN biopsy must be very accurate and 
consistent. Accuracy depends on the tracing technique, 
the surgical procedure, and the extensiveness of 
pathological sampling of SLNs. Currently, data on the 
effectiveness of SLN biopsy on the long-term survival 
of patients with breast cancer are lacking. However, 
a review of the available evidence demonstrates that, 
when performed by experienced clinicians, it appears to 
be a safe and acceptably accurate method for identifying 
early-stage breast cancer, in patients without axillary 
lymph node involvement.
 As for the prognostic significance of SLN, there are 
at least two issues: (1) negative SLN but positive non-
SLNs, and (2) metastasis and micrometastasis.
 A negative SLN biopsy but positive non-SLNs raises 
a concern about how reliable such testing is as compared 
to conventional methods of staging, axillary dissection, 
and conventional histological examination. A non-SLN,
which is fully or partly replaced by metastasis, was prob-
ably once a SLN but no longer functional, because of 
tumour replacement. This forced lymphatic drainage via 
collaterals to a new lymph node, which becomes the 
current SLN, results in the phenomenon whereby tumour 
cells skip the SLN and get metastasised to other lymph 
nodes. Fortunately, the incidence of negative SLN but 
positive non-SLN is low. In one study, only one of 1087 
non-SLNs was found to contain tumour in 60 patients with 
negative SLNs by histological and immunohistochemical 
examination.6 In a cohort study of breast cancer patients 
with a negative SLN biopsy, only one (1%) of all patients de-
veloped a lymphatic recurrence in the axilla after a me-
dian follow-up of 2 years.7 This study indicates that SLN bi-
opsy provides accurate staging of the cancer and that patients 
whose biopsy is negative do not require axillary dissection.
 The issue of metastasis and micrometastasis in 
SLNs is currently under much investigation.8 In the paper 
by Leung et al,1 five of six patients whose SLN biopsies 
yielded false-negative results intra-operatively but positive 
final results, did not opt for second surgery. Also, in 
patients whose SLNs were positive in this paper, it would 
be useful to know how many had positive non-SLNs in the 
axillary dissection specimens. An analysis of multicentre 
results has shown non-SLN tumour involvement in 18% 
of SLNs with micrometastases or isolated tumour cells.3 
On the other hand, the prognostic significance of SLN 
micrometastases (>0.2 mm and <2.0 mm) has not yet 
been determined.4 This begs the question as to whether 
patients with positive SLNs, particularly those with 
micrometastases, require completion axillary dissection. 
Until this is clear, current procedures directed toward 
detecting micrometastases or isolated tumour cells may be 
regarded as largely experimental in relation to the overall 
prognosis. Randomised clinical trials targeted at SLN-
positive patients receiving axillary dissection, radiotherapy, 
or observation are needed to address this issue.
Which method—intra-operative 
consultation or formalin-fixation with 
paraffin embedding—for sentinel lymph 
nodes?
Histopathological examination of the SLN may be 
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performed after fixation and embedding in paraffin or 
intra-operatively. The choice between the two different 
procedures depends on individual institutions. The 
major advantage of intra-operative assessment is that if 
the biopsy is found to be positive intra-operatively, it can 
save a second operation, for which reason this practice 
is much advocated for in European countries.3 The 
intra-operative consultation can employ either frozen 
sections or touch imprints. Touch imprints have a high 
false-negative rate and not all pathologists are used to 
interpreting them, but they are much faster and tissue is 
not destroyed during processing.
 Intra-operative frozen section assessment has its 
own limitations3,4 because it involves trimming away of 
substantial amounts of tissue, therefore there is always 
uncertainty as to whether microscopic metastasis that 
may be present is discarded. This shortcoming may 
perhaps be overcome to certain extent by flat embedding 
the bisected lymph node, which avoids trimming away 
any embedded tissue. Introduction of tissue artifacts 
interfering with permanent section analysis is another 
drawback. With intra-operative consultation, surgical 
time is prolonged, with increasing costs. There can 
also be false positives due to, for example, glandular 
inclusions, though fortunately these are not common. 
However, saving the patient from a second operation 
may outweigh all these disadvantages.
 Intra-operative assessment of SLN is currently 
considered an optional procedure. The practice of 
intra-operative consultation using frozen section is not 
universal in pathology laboratories worldwide or locally. 
There are concerns from pathology laboratories regarding 
radiation risk, risk of significant damage and destruction 
of potentially diagnostic tissue, relatively high FNR for 
micrometastases, as well as manpower and resource 
implications. An understanding of an inevitable FNR by 
the surgeons and pathologists is critical, and requires 
an active dialogue among the multidisciplinary team of 
surgeons, pathologists, and nuclear medicine colleagues 
to optimise practice in individual institutions.
 In summary, SLN biopsy is very much a 
multidisciplinary team effort with active involvement of 
surgeons, pathologists, radiologists, and nuclear medicine 
colleagues among others. With careful pathological 
examination, valuable information can be obtained from 
the procedure. Patients with breast cancer can then be 
further stratified with regard to prognosis and therapy. 
Intra-operative consultation for SLN can save patients a 
second operation. Although there are limitations to the 
technique, its application as a standard practice should 
be considered according to the resources available in 
individual institutions. Delineation of the significance of 
micrometastases in SLN, in terms of predicting further 
nodal involvement, prognosis and indication of adjuvant 
therapy will have an impact on the extent of histological 
work-up that is necessary.
Fine-needle aspiration cytology in 
thyroid nodule
The usefulness of fine-needle aspiration cytology 
(FNAC) in making diagnosis for thyroid nodules is 
well established and exemplified again in the study 
by Cheung et al2 in this issue. They have reported the 
sensitivity, specificity, positive and negative predictive 
values of FNAC for thyroid nodules to be 54, 100, 100, 
and 75%, respectively. Despite the modest size of their 
samples, these figures are comparable to those reported 
in the literature.9,10
 According to a recent review, the range of 
inadequate or unsatisfactory specimens for thyroid 
FNAC varies from 2 to 21% (mean of 17%),11 which is 
consistent with the rate of 15% reported in the study by 
Cheung et al.2 Such rates vary widely in different centres, 
depending on local sampling policies. The experience 
of clinicians or pathologists performing the FNAC—
whether as part of a small group of designated specialists 
undertaking FNAC—, the number of aspirates and slides 
taken per aspirate can significantly affect the yield. On 
the other hand, use of ultrasound guidance reduces the 
rate of inadequate FNAC procedures by at least two 
fold.12
 In conclusion, the work described by Leung 
et al1 and Cheung et al2 is a valuable contribution to the 
ongoing attempts to provide various updated means 
of pathology reporting directed at cancers. The former 
highlights the application of intra-operative frozen 
section assessment of SLNs in the management of breast 
cancer and the latter emphasises the usefulness of FNAC 
in the diagnosis of thyroid cancer.
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